1. Home
  2. WST vs CPAY Comparison

WST vs CPAY Comparison

Compare WST & CPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • CPAY
  • Stock Information
  • Founded
  • WST 1923
  • CPAY 1986
  • Country
  • WST United States
  • CPAY United States
  • Employees
  • WST N/A
  • CPAY N/A
  • Industry
  • WST Medical/Dental Instruments
  • CPAY EDP Services
  • Sector
  • WST Health Care
  • CPAY Technology
  • Exchange
  • WST Nasdaq
  • CPAY Nasdaq
  • Market Cap
  • WST 18.9B
  • CPAY 22.2B
  • IPO Year
  • WST N/A
  • CPAY 2010
  • Fundamental
  • Price
  • WST $257.65
  • CPAY $305.15
  • Analyst Decision
  • WST Strong Buy
  • CPAY Buy
  • Analyst Count
  • WST 8
  • CPAY 13
  • Target Price
  • WST $329.43
  • CPAY $394.33
  • AVG Volume (30 Days)
  • WST 552.4K
  • CPAY 365.0K
  • Earning Date
  • WST 10-23-2025
  • CPAY 11-06-2025
  • Dividend Yield
  • WST 0.35%
  • CPAY N/A
  • EPS Growth
  • WST N/A
  • CPAY 6.87
  • EPS
  • WST 6.68
  • CPAY 14.72
  • Revenue
  • WST $2,960,200,000.00
  • CPAY $4,171,325,000.00
  • Revenue This Year
  • WST $6.28
  • CPAY $14.00
  • Revenue Next Year
  • WST $6.02
  • CPAY $10.51
  • P/E Ratio
  • WST $37.92
  • CPAY $20.76
  • Revenue Growth
  • WST 2.90
  • CPAY 9.22
  • 52 Week Low
  • WST $187.43
  • CPAY $269.02
  • 52 Week High
  • WST $352.33
  • CPAY $400.81
  • Technical
  • Relative Strength Index (RSI)
  • WST 59.59
  • CPAY 39.74
  • Support Level
  • WST $253.38
  • CPAY $302.39
  • Resistance Level
  • WST $264.06
  • CPAY $314.42
  • Average True Range (ATR)
  • WST 5.62
  • CPAY 6.64
  • MACD
  • WST 0.64
  • CPAY -1.36
  • Stochastic Oscillator
  • WST 71.41
  • CPAY 10.93

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About CPAY Corpay Inc.

Corpay Inc is a corporate payments company that helps businesses and consumers manage and pay their expenses. Its suite of modern payment solutions helps customers manage vehicle-related expenses, lodging expenses, and corporate payments. Its reportable segments are; Vehicle Payments, Corporate Payments, Lodging Payments, and Other. The group's geographic areas are the United States, Brazil, the United Kingdom, and Other.

Share on Social Networks: